Cancers Treated:
Specializing In:
- Neuropathology
- Thoracic pathology
- GI pathology
Research Interests:
- Brain tumor
- Tumorigenesis
- Graft vs Host Disease
Positions
Roswell Park Comprehensive Cancer Center
- Professor of Oncology
- Director of Oncological Surgical Pathology Fellowship Program
- Director of Clinical Immunohistochemistry Laboratory
- Head of Neuropathology Service
- Department of Pathology & Laboratory Medicine
Background
Education and Training
- 2001 - PhD - University of Texas Medical Branch, Galveston, TX
- 1992 - MD - Beijing Medical University
Residency
- 07/2003-06/2005 - Anatomic Pathology, University of Florida
Fellowship
- 07/2005-06/2007 - Neuropathology Fellow, Department of Pathology, University of Florida
- 07/2009-06/2010 – Oncological Surgical Pathology Fellow, Roswell Park Cancer Institute
Board Certification
- Anatomic Pathology and Neuropathology
Publications
1. Hemn Mohammadpour, Takemasa Tsuji, Cameron MacDonald, Sarah Choi, Saeed Daneshmandi, Kunle Odunsi, Jingxin Qiu, Hanna Rosenheck, Junko Matsuzaki, Agnieszka Witkiewicz, Bruce Blazar, Elizabeth Repasky Subjeck, Philip McCarthy. Galectin-3 Expression in Donor T cells Reduces GvHD Severity and Lethality after Allogeneic Hematopoietic Cell Transplantation. Cell Reports, 2023 Mar 28;42(3):112250. doi: 10.1016/j.celrep.2023.112250. Epub 2023 Mar 15.
2. Victor Goulenko, Venkatesh Shankar Madhugiri, Amade Bregdy, Matthew Recker, Lindsay Lipinski, Andrew Fabiano, Robert Fenstermaker, Robert Plunkett, Ajay Abad, Ahmed Belal, Ronald Alberico, Jingxin Qiu, Dheerendra Prasad. Histopathological correlation of brain tumor recurrence vs radiation effect post-radiosurgery as detected by MRI Contrast Clearance Analysis: A validation study. May 2024, Journal of Neuro-Oncology 168(3):1-7. DOI: 10.1007/s11060-024-04697-0
3. Tara A. Barone, Denisha Robinson, Jingxin Qiu, Katerina V. Gurova, Andrei A. Purmal, Andrei V. Gudkov, and Robert J. Plunkett. FACT inhibitor CBL0137, administered in an optimized schedule, potentiates radiation therapy for glioblastoma by suppressing DNA damage repair. Journal of Neuro-Oncology, 2024 Dec;170(3):621-630. doi: 10.1007/s11060-024-04819-8
4. Elizabeth Nyabuto, Robert A. Fenstermaker, Jingxin Qiu. Secondary IDH-mutant gliosarcoma in a patient with prior IDH-mutant grade II astrocytoma. Journal of Neuropathology & Experimental Neurology. 2025, Volume 84, Issue 7, July, Pages 655–657, https://doi.org/10.1093/jnen/nlae131
5. Henry G. Withers, Sheila A. Figel, Jingxin Qiu, Manmeet S. Ahluwalia, David A. Reardon, Ajay P. Abad, William T. Curry, Eric T. Wong, David M. Peereboom, Andrew Dhawan, Song Liu, Michael J. Ciesielski, and Robert A. Fenstermaker. Intratumoral B cell and interferon signatures in newly diagnosed glioblastoma are associated with longer survival in patients treated with SurVaxM. Cancer Immunology, Immunotherapy, 2025 Oct 9;74(11):332. doi: 10.1007/s00262-025-04193-y.